Pharma BD Deal Intelligence

Amgen Inc. / Abgenix Inc.

2005 · Acquisition/Merger · $2.2B · Complete

Antibody platform; full ownership panitumumab + denosumab royalty elimination; announced 2005-12-14, closed 2006-04-03

Key facts

• Announced Dec 14, 2005
• Deal value $2.2B
• Deal type Acquisition/Merger

← Browse all deals  ·  How we score deals